NGS Based RNA Seq Market Size, Trends and Growth Analysis by 2027

The report on the NGS-based RNA sequencing market indicates that it is projected to grow from US$ 1,414.59 million in 2018 to US$ 7,984.90 million by 2027. This growth represents a compound annual growth rate (CAGR) of 19.3% over the period from 2018 to 2027.

The expansion of the NGS-based RNA sequencing market is primarily fueled by several key factors, including the decreasing costs associated with genome sequencing, significant advancements in sequencing technologies, and the application of next-generation sequencing in cancer research. However, the market may encounter challenges such as concerns regarding genetic data privacy and the high expenses associated with NGS instruments. A notable trend anticipated to enhance market growth is the implementation of barcode scanning for long-read sequences.

In terms of product and service offerings, the NGS-based RNA sequencing market is categorized into several segments: sample preparation, sequencing services, sequencing platforms and consumables, as well as data analysis, storage, and management. Among these, the sequencing platform segment held the largest market share in 2018, accounting for 38.3% of the NGS-based RNA sequencing market, and is expected to maintain its leading position throughout the forecast period from 2018 to 2027. The sample preparation segment is further divided into methods and workflow steps. The methods are classified into manual and automated categories, while the workflow steps include library preparation and target enrichment, fragmentation, end repair and size selection, and quality control. It is anticipated that the automated method will dominate the market during the forecast period, particularly in the library preparation and target enrichment workflow steps.

The technology segment of the NGS-based RNA sequencing market encompasses various methodologies, including sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing, and single-molecule real-time (SMRT) sequencing. Valued at US$ 1,414.59 million in 2018, this segment is projected to reach US$ 7,984.90 million by 2027. It is expected to be the fastest-growing segment during the forecast period due to the advantages offered by NGS-based RNA sequencing, such as enhanced accuracy in gene expression analysis, applicability across diverse species, and relatively lower costs for various arrays. Companies in this sector provide numerous benefits to researchers through their innovative products. For example, Illumina, Inc. offers systems that utilize sequencing by synthesis technology, which is widely adopted globally for next-generation sequencing. The SBS technology is known for its robust performance, high data quality, and accurate base calling, which are likely to drive market growth in the coming years.

The report on the NGS-based RNA sequencing market incorporates insights from various primary and secondary sources, including the National Institutes of Health, the National Science Foundation, the Canada Foundation for Innovation, the African Society of Human Genetics, the Department of Biotechnology, the Dubai Health Authority, Human Heredity and Health in Africa, the French National Cancer Institute, the Japan Science and Technology Agency, the Trinity Translational Medicine Institute, among others.